Skip to main content
Developmental Immunology logoLink to Developmental Immunology
. 2001;8(3-4):259–266. doi: 10.1155/2001/45454

Human FDC express PrPc in vivo and in vitro

Caroline Thielen 1, Nadine Antoine 1, France Mélot 1, Jean-Yves Cesbron 2, Ernst Heinen 1, Rikiya Tsunoda 3,
PMCID: PMC2276072  PMID: 11785675

Abstract

Prion diseases are fatal neurodegenerative disorders caused by accumulation of abnormal prion protein (protease-resistant prion, PrPres). PrPres accumulation is also detected in lymphoid organs after peripheral infection. Several studies suggest that follicular dendritic cells (FDC) could be the site of PrPres retention and amplification.

Here we show that human follicular dendritic cells can express normal cellular prion protein (PrPc) both in situ and in vitro. When tonsillar cryosections were treated with anti-PrP antibody, the label was found on some very delicate cell extensions inside the lymphoid follicles, especially in the germinal centres. These extensions react with DRC1 antibody, used frequently to label FDC. Other structures labelled with anti-PrP antibody were the keratinocytes.

To confirm the ability of FDC to synthesise PrPc, we isolated FDC by a non-enzymatic procedure and cultured them. By cytochemistry and flow cytometry it was clearly shown that FDC do produce PrPc.

Keywords: Follicular Dendritic Cells (FDC), germinal centre, human tonsil, immunolabelling, prion protein (PrPc)

Full Text

The Full Text of this article is available as a PDF (1.3 MB).


Articles from Developmental Immunology are provided here courtesy of Wiley

RESOURCES